Thymidine phosphorylase in human esophageal squamous cell carcinoma

Cancer

Volumn 85, Issue 2, 1999, Pages 282-289

  Takebayashi, Yuji ^a   Natsugoe, Shoji ^a   Baba, Masamichi ^a   Akiba, Suminori ^a   Fukumoto, Toshitaka ^a   Miyadera, Kazutaka ^b   Yamada, Yuji ^b   Takao, Sonshin ^a   Akiyama, Shin Ichi ^c   Aikou, Takashi ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b TAIHO PHARMACEUTICAL CO LTD   (Japan)

^c KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Angiogenesis; Esophageal carcinoma; Me tastasis; Thymidine phosphorylase

Indexed keywords

BLOOD CLOTTING FACTOR 8; THYMIDINE PHOSPHORYLASE;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER INVASION; CAPILLARY DENSITY; CLINICAL FEATURE; ENZYME ACTIVITY; ENZYME INHIBITION; ESOPHAGUS CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MINIMAL RESIDUAL DISEASE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REGRESSION ANALYSIS; SEQUENCE HOMOLOGY; SQUAMOUS CELL CARCINOMA;

AGED; AGED, 80 AND OVER; ANGIOGENESIS INDUCING AGENTS; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; GASTRIC MUCOSA; HUMANS; MALE; MICROCIRCULATION; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; THYMIDINE PHOSPHORYLASE; TUMOR MARKERS, BIOLOGICAL;

EID: 0032918950     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19990115)85:2<282::AID-CNCR3>3.0.CO;2-T     Document Type: Article

References (49)

1. Iltzssch MH, Kouni MH, Cha, S. Kinetic studies of thymidine phosphorylase from mouse liver. Biochemistry 1985;24: 6799-807.
2. Friedkin D, Roberts D. The enzymatic synthesis of nucleosides. J Biol Chem 1954;207:245-56.
3. Krenistsky TA, Koszalka GW, Tuttle JV. Purine nucleoside synthesis, an efficient method employing nucleoside phosphorylase. Biochemistry 1981;20:3615-21.
4. Zimmerman M, Seidenberg J. Deoxyribosil transfer. J Biol Chem 1964;230:2618-21.
5. Gallo RC, Perry S, Breitman TR. The enzymatic mechanisms for deoxythymidine synthesis in human leukocytes. J Biol Chem 1967;242:5059-68.
6. Krenitsky TA. Pentosyl transfer mechanisms of the mammalian nucleoside phosphorylases. J Biol Chem 1968;243: 2871-5.
7. Desgranges C, Razaka G, Rabaud H. Catabolism of thymidine in human blood platelets: purification and properties of thymidine phosphorylase. Biochim Biophys Acta 1981; 654:211-8.
8. Furukawa T, Yosimura A, Sumizawa T, Haraguchi M, Akiyama S, Fukui K, Ishizawa M, Yamada Y. Angiogenic factor. Nature 1992;356:668.
9. Sumizawa T, Furukawa T, Haraguchi M, Akiyama S, Fukui K, Ishizawa M, Akiyama S. Thymidine phosphorylase activity associated with platelet-derived endothelial cell growth factor. J Biochem (Tokyo) 1993;114:9-14.
10. Haraguchi M, Miyadera K, Uemura K, Sumizawa T, Furukawa T, Yamada K, Akiyama S, Yamada Y. Angiogenic activity of enzymes. Nature 1994;368:198.
11. Ishikawa F, Miyazono K, Hellman U, Drexler M, Wernstedt C, Hagiwara K, Usuki K, Takaku F, Risau W, Heldin CH. Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature 1989;338:556-62.
12. Miyazono K, Okabe T, Urabe A, Takaku F, Heldin CH. Purification and properties of an endothelial cell growth factor from human platelets. J Biol Chem 1987;262:4098-103.
13. Miyadera K, Sumizawa T, Haraguchi M, Yoshida H, Konstanty W, Yamada Y, Akiyama S. Role of thymidine phosphorylase activity in the angiogenic effect of platelet-derived endothelial cell growth factor/thymidine phosphorylase. Cancer Res 1995;55:1687-90.
14. Moghaddam A, Zhang HT, Fan TPD, Hu DE, Lees VC, Turley H, Fox SB, Gatter KC, Harris AL, Bickneel R. Thymidine phosphorylase is angiogenic and promotes tumor growth. Proc Natl Acad Sci USA 1995;92:998-1002.
15. Toi M, Hoshina S, Taniguchi T, Yamamoto Y, Ishituka H, Tominaga T. Expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast cancer. Int J Cancer 1995;14:79-82.
16. Reynold K, Farzaneh F, Collins WP, Harris AL. Association of ovarian malignancy with expression of platelet-derived endothelial cell growth factor. J Natl Cancer Inst 1994;86:1234-8.
17. Pauly JL, Schuller MG, Zelcer AA, Kris TA, Gore SS. Identification and comparative analysis of thymidine phosphorylase in the plasma of healthy subjects and cancer patients: brief communication. J Natl Cancer Inst 1997;58:1587-90.
18. Kono A, Hara Y, Sugata S. Substrate specificity of a thymidine phosphorylase in human liver tumor. Chem Pharmacol Bull 1984;32:1919-21.
19. Yoshimura A, Kuwazuru Y, Furukawa T, Yoshida H, Yamada K, Akiyama S. Purification and tissue distribution of human thymidine phosphorylase; high expression in lymphocytes, reticulocytes and tumors. Biochim Biophys Acta 1990;1034: 107-13.
20. Takebayashi Y, Yamada K, Maruyama I, Fujii R, Akiyama S, Aikou T. The expression of thymidine phosphorylase and thrombomodulin in human colorectal carcinomas. Cancer Lett 1995;92:1-7.
21. O'Brien T, Cranston D, Fuggle S, Bicknell R, Harris AL. Different angiogenic pathways characterize superficial and invasive bladder cancer. Cancer Res 1995;55:510-3.
22. Takebayashi Y, Yamada K, Miyadera K, Sumizawa T, Furukawa T, Kinoshita F, Aoki D, Okumura H, Yamada Y, Akiyama S, Aikou T. The activity and expression of thymidine phosphorylase in human solid tumors. Eur J Cancer 1996;32:1227-32.
23. Takebayashi Y, Miyadera K, Akiyama S, Hokita S, Yamada Y, Akiba S, Yamada Y, Sumizawa T, Aikou T. Expression of thymidine phosphorylase in human gastric carcinoma. Jpn J Cancer Res 1996;87:288-95.
24. Maeda K, Chung YS, Ogawa Y, Takatsuka S, Kang SM, Ogawa M, Sawada T, Onda N, Kato Y, Sowa M. Thymidine phosphorylase/platelet-derived endothelial cell growth factor expression associated with hepatic metastasis in gastric carcinoma. Br J Cancer 1996;73:884-8.
25. Takebayashi Y, Akiyama S, Akiba S, Yamada K, Miyadera K, Sumizawa T, Yamada Y, Murata F, Aikou T. Clinicopathologic and prognostic significance of an angiogenic factor, thymidine phosphorylase, in human colorectal carcinoma. J Natl Cancer Inst 1996;88:1110-7.
26. Folkman J, Hagsbrun M. Angiogenic factor. Science 1987; 235:442-7.
27. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990;82:4-6.
28. Liotta L, Kleinerman J, Saidel G. Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation. Cancer Res 1974; 34:997-1004.
29. Srivastava A, Laidler P, Hughes LE, Woodcock J, Shedden EJ. Neovascularization in human cutaneous melanoma; a quantitative morphological and Doppler ultrasound study. Eur J Cancer Clin Oncol 1986;22:1205-9.
30. Srivastava A, Laidler P, Davis RP, Horgan K, Hughes LE. The prognostic significance of tumor vascularity in intermediate-thickness (0.76-4.0 mm thick) skin melanoma: a quantitative histologic study. Am J Pathol 1988;133:419-23.
31. Herlyn M, Clark WH, Rodeck U, Mancianti ML, Jambrosic I, Koprowski H. Biology of tumor progression in human melanocytes. Lab Invest 1987;56:461-74.
32. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med 1991;324:1-8.
33. Horak ER, Leek R, Klenk N, Lejeune S, Smith K, Stuart N, Harris AL. Angiogeneis, assessed by platelet-derived cell adhesion molecular antibodies, as indicator of node metastases and survival in breast cancer. Lancet 1992;340:1120-14.
34. Weidner N, Carroll PR, Flax J, Blumenfeld W, Folkman J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 1993;143:401-9.
35. Macchiarini P, Fontanini G, Hardin MJ, Squartini F, Angeletti CA. Relation of neovascularization to metastasis of non-small-cell lung cancer. Lancet 1992;340:145-6.
36. Yamazaki K, Abe S, Takekawa H, Sudou N, Watanabe N, Ogura S. Tumor angiogenesis in human lung adenocarcinoma. Cancer 1995;74:2245-50.
37. Maeda K, Chung YS, Takatsuka S, Ogawa Y, Sawada T, Kondo Y, Sowa M. Tumor angiogenesis as a predictor of recurrence in gastric carcinoma. J Clin Oncol 1995;13:477-81.
38. Takebayashi Y, Akiyama S, Yamada K, Akiba S, Aikou T. Angiogenesis as an unfavorable prognostic factor in human colorectal carcinoma. Cancer 1996;78:226-31.
39. World Health Organization. International histologic classification of tumors: histological typing of esophageal and gastric tumors. 2ne ed. Berlin: Spring Verlag, 1990.
40. Hermanek P, Sobin LH, editors. UICC TNM classification of malignant tumors. 4th ed, 2nd rev. Berlin: Spring-Verlag, 1992.
41. Hsu SM, Raine L, Fanger AH. A comparative study of the peroxidase method and an avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibody. Am J Clin Pathol 1981;75:734-8.
42. Breslow NE, Day NE. Statistical methods in cancer research. 1987.
43. Zar JH. Biostatistical analysis. 2nd ed. Totowa, NJ: Prentice Hall Press, 1996.
44. Preston DL, Lubin JH, Pierce DA. EPICURE: risk regression and data analysis software. Seattle: HiroSoft International Corporation, 1990.
45. Kaplan EL, Meier P. Nonparametric estimation from incomplete observation. J Am Stat Assoc 1997;16:95-101.
46. Usuki K, Saras J, Waltenberger J, Miyazono K, Pierce G, Thomason A, Heldin CH. Platelet-derived endothelial cell growth factor has thymidine phosphorylase activity. Biochem Biophys Res Commun 1992;84:1311-4.
47. Moghaddam A, Bicknell R. Expression of platelet-derived endothelial cell growth factor in Escherichia coli and confirmation of its thymidine phosphorylase activity. Biochemistry 1992;31:12141-6.
48. Nishimoto K, Miyadera K, Takebayashi Y, Fukuda K, Haraguchi M, Furukawa T, Yamada, Y, Akiyama S. Thymidine phosphorylase activity required for tumor angiogenesis and growth. Oncol Rep 1997;4:55-8.
49. Fox SB, Westwood M, Moghaddam A, Comely M, Turley H, Whitehouse RM, Bicknell R, Gatter KC, Harris AL. The angiogenic factor platelet-derived endothelial cell growth factor/thymidine phosphorylase is up-regulated in breast cancer epithelium. Br J Cancer 1996;73:275-80.